Lengo Therapeutics, Inc. — Form D
Lengo Therapeutics, Inc. of Menlo Park, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-09. The offering totals $16.0M, of which $4.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-04-09
- Form: D
- Accession: 0001567619-20-007782
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $16.0M
- Amount sold: $4.4M
- Remaining: $11.6M
- Investors: 1
- Date of first sale: 2020-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364705
Issuer
- Name: Lengo Therapeutics, Inc.
- CIK: 0001808546
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 70 Willow Road, Suite 200, Menlo Park, CA, 94025
- Phone: (650) 325-5156
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Tracy Saxton, Ph.D. | Executive Officer | Menlo Park, CA |
| David Johnson | Director | Greenwood Village, CO |
| Anna Chen | Executive Officer | Palo Alto, CA |
| STEVE BAILEY | Executive Officer | SEATTLE, WA |
| Daniel Estes, Ph.D. | Director | Menlo Park, CA |
| Daniel Estes, Ph.D. | Executive Officer | Menlo Park, CA |
| Tracy Saxton, Ph.D. | Director | Menlo Park, CA |
| Helen Jenkins | Director | Menlo Park, CA |
| Helen Jenkins | Executive Officer | Menlo Park, CA |
| Roger Ulrich, Ph.D. | Director | Menlo Park, CA |
Other filings by this issuer (1)
More